Meeting
2024 ASCO Gastrointestinal Cancers Symposium
A prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in JAPAN: ENSEMBLE-1 study.
Authors
Yoshinori Kagawa
Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan
Yoshinori Kagawa , Jun Watanabe , Koji Ando , Mamoru Uemura , Akira Inoue , Koji Oba , Ichiro Takemasa , Eiji Oki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
jRCT s051200113
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 123)
DOI
10.1200/JCO.2024.42.3_suppl.123
Abstract #
123
Poster Bd #
H8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
No operation after short course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer: The prospective, single arm NOAHS-ARC trial.
First Author: Felipe Fernando Quezada
Poster
2021 Gastrointestinal Cancers Symposium
Short-course radiotherapy and subsequent CAPOX plus camrelizumab followed by delayed surgery for locally advanced rectal cancer: Short-term results of a phase II trial.
First Author: Zhenyu Lin
Poster
2024 ASCO Breakthrough
Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.
First Author: Yoshinori Kagawa
Poster
2024 ASCO Annual Meeting
Total neoadjuvant therapy with split-course hypofraction radiotherapy combined with CAPOX and envafolimab followed by local excision for locally advanced very low rectal cancer (TRACE-LE): An open-label, single-arm, multicenter, phase II trial.
First Author: Weizhong Jiang